Sobi North America, a subsidiary of Swedish Orphan Biovitrum AB, announced that the U.S. Food and Drug Administration has granted authorization for their arthritis drug to be used in the treatment of hospitalized COVID-19 patients at high risk. This comes as an exciting development given the drug’s previous approval in the European Union for treating COVID-19. It’s like a new tool in the shed that is proving to be effective against the virus! The FDA’s decision demonstrates their recognition of the potential benefit this drug can provide to those who are more vulnerable to severe illness from COVID-19. With the authorization in place, high-risk patients now have access to this additional treatment option. Perhaps further research could explore whether this drug could be effective in treating mild or moderate COVID-19 cases as well. If you want to dive deeper into the details, check out the article linked below!
Sobi North America, a unit of Swedish Orphan Biovitrum AB, said on Thursday the U.S. Food and Drug Administration authorized its arthritis drug for treatment of high-risk hospitalized COVID-19 patients. The drug, already approved in the European Union for treating COVID, has…
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.